Kiran K. Bhatt
基兰·巴特
MD
Associate Professor, Department of Surgical Oncology外科肿瘤学系副教授
👥Biography 个人简介
Kiran Bhatt is a surgical oncologist at MD Anderson Cancer Center specializing in peritoneal surface malignancies and GI surgical oncology. Her research focuses on outcomes of CRS + HIPEC in colorectal and gastric peritoneal metastases, neoadjuvant systemic therapy integration, and improving patient selection through molecular and radiological biomarkers in one of the world's highest-volume HIPEC centers.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Gastric Cancer Peritoneal Metastases and HIPEC
Investigated CRS + HIPEC outcomes and patient selection for gastric cancer peritoneal metastases at MD Anderson, contributing to institutional protocols for multimodal treatment incorporating perioperative systemic therapy.
Neoadjuvant Therapy Integration with CRS + HIPEC
Analyzed the impact of neoadjuvant chemotherapy on peritoneal disease response and CRS + HIPEC outcomes, providing evidence for treatment sequencing in colorectal and gastric peritoneal metastases.
Biomarker-Based Patient Selection for HIPEC
Contributed research on molecular and imaging biomarkers to refine patient selection for CRS + HIPEC, improving outcomes through better identification of patients likely to achieve complete cytoreduction and durable survival.
Representative Works 代表性著作
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for gastric cancer with peritoneal carcinomatosis
Annals of Surgical Oncology (2018)
Single-institution analysis from MD Anderson reporting CRS + HIPEC outcomes for gastric peritoneal carcinomatosis, defining selection criteria for this high-risk group.
Impact of neoadjuvant chemotherapy on peritoneal cancer index and cytoreductive surgery outcomes in colorectal peritoneal metastases
Journal of Surgical Oncology (2020)
Demonstrated that neoadjuvant chemotherapy can reduce peritoneal disease burden and improve complete cytoreduction rates in colorectal peritoneal metastases.
Contemporary outcomes of hyperthermic intraperitoneal chemotherapy at a high-volume cancer center
Surgery (2022)
Comprehensive analysis of modern CRS + HIPEC outcomes across tumor histologies at MD Anderson, demonstrating improving morbidity and survival with institutional experience.
🏆Awards & Recognition 奖项与荣誉
📄Data Sources 数据来源
Last updated: 2026-01-15 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 基兰·巴特 的研究动态
Follow Kiran K. Bhatt's research updates
留下邮箱，当我们发布与 Kiran K. Bhatt（The University of Texas MD Anderson Cancer Center）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment